Latest News


Lab-grown organoids, mimicking fallopian tubes, could help prevent ovarian cancer, research shows

UCLA Health Connect blog

Post Date:January 06, 2022 6:00 AM
Dr. Beth Karlan, a professor of obstetrics and gynecology in the David Geffen School of Medicine at UCLA

Ovarian cancer is the leading cause of gynecologic cancer death in the U.S. UCLA Health’s Beth Karlan, MD, working with stem cell researcher Clive N. Svendsen, PhD, has developed what promises to be a game-changing approach in the treatment of ovarian cancer, a silent killer that often goes undetected until its final stages. 

Ovarian cancer strikes almost two out of every 100 women. But for those who carry a mutated form of the BRCA1 gene, their risk of developing this most deadly of all gynecological diseases is 30 times higher than among the general population.

Gaining a better understanding of this hereditary genetic threat is one of the most pressing issues in gynecologic health. For that reason, it has become the life’s work of internationally renowned gynecological oncologist Dr. Karlan, a pioneer in her field and director of Cancer Population Genetics at the UCLA Jonsson Comprehensive Cancer Center.

Click here to read the UCLA Health Connect blog.

Return to full list >>